Abstract View

Author(s): Rahil Salim Meman1*1, Furkhan Khan Younus Khan22

Email(s): 1memon.rahil99@gmail.com

Address:

    1 Department of Pharmaceutics, Ismail Mehta College of Pharmacy, Ambad. 2 Department of Pharmacology, Ismail Mehta College of Pharmacy, Ambad.

Published In:   Volume - 5,      Issue - 2,     Year - 2026

DOI: https://doi.org/10.71431/IJRPAS.2026.5202  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
The scarcity of compatible blood for transfusion remains a critical challenge in emergency medicine, particularly in trauma, surgical, and battlefield scenarios[1]. Plastic blood, or synthetic blood substitutes, represent a transformative advancement in addressing this global shortage. These engineered solutions utilize hemoglobin-based oxygen carriers (HBOCs) and perfluorocarbon products to provide immediate oxygen delivery without requiring blood typing or compatibility testing[2]. This research paper examines the current state of plastic blood technology, including its composition, mechanisms of action, clinical applications, advantages over traditional blood transfusions, and ongoing challenges in achieving widespread clinical implementation.

Cite this article:
Rahil Salim Meman, Furkhan Khan Younus Khan. Plastic Blood: Synthetic Blood Substitutes in Emergency Medicine for Patient Transfusion. IJRPAS, February 2026; 5(2): 11-19.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2026.5202


1.    NHLBI. (2024). Potential game-changer for emergency medicine: Synthetic platelets. National Institutes of Health. https://www.nhlbi.nih.gov/news/2024/potential-game-changer-emergency-medicine-synthetic-platelets

2.    NIH/PMC. (2024). Artificial blood for therapeutic and laboratory usage. PubMed Central, 11427025. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11427025/

3.    NIH/PMC. (1999). Blood substitutes: Haemoglobin therapeutics in clinical use. Transfusion Medicine Reviews, 13(4), 1-25. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC137240/

4.    NIH/PMC. (2020). Artificial blood: The history and current perspectives of hemoglobin-based oxygen carriers. Frontiers in Medicine, 7, 86. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC7086064/

5.    Science Magazine. (2024, July 2). The ultimate blood substitute? The U.S. military is betting $46 million. Science, 385(6), 245-248. https://www.science.org/content/article/ultimate-blood-substitute-us-military-betting-46-million

6.    NPR. (2025, July 24). Scientists are developing artificial blood that could save lives. Shots - Health News. https://www.npr.org/sections/shots-health-news/2025/07/24/nx-s1-5477632/artificial-blood-hemorrhage-emergency-medicine

7.    NIH/PMC. (2018). Artificial blood: A futuristic dimension of modern day transfusion medicine. Journal of Laboratory Medicine, 42(6), 234-245. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC6864588/

8.    ASH Clinical News. (2025, February 19). Banking on artificial blood. American Society of Hematology Clinical News. https://ashpublications.org/ashclinicalnews/news/8465/Banking-on-Artificial-Blood

9.    Al Jazeera. (2025, March 8). How close are scientists to producing artificial blood? Retrieved from https://www.aljazeera.com/news/2025/3/8/how-close-are-scientists-to-producing-artificial-blood

Related Images:



Recent Images



Evaluation of In-Vitro Anti-Diabetic Activity And   Antioxidant Activity In Ethanolic and Hydroalcoholic Extract of leaves of Gymnema Sylvestre
Molecular Docking Approaches in Antibacterial Drug Discovery: Computational Insights into Natural Compounds
In-vitro Evaluation of Anti-Urolithiatic Activity of Hydroalcoholic Extract of Centella asiatica Leaves
Quality by Design (Qbd) Based Method Development and Validation of Trelagliptin Succinate byu RP-HPLC.
Cubosomes: Structure, Preparation Methods, Characterization, and Pharmaceutical Applications
Programmable Oral Drug Delivery Systems: Materials, Device Engineering, Stimuli-Responsive Mechanisms, and Clinical Translation
Biomimetic Nanocarrier for Targeted Drug Delivery: An Integrated Review
From Phosphate Wasting to Targeted Therapy: An Updated Review of FGF23-Mediated Hypophosphatemic Rickets
Nanotechnology-Based Drug Delivery Systems for Alzheimer’s Disease: Emerging Strategies for Blood–Brain Barrier Targeting
Explainable AI in Pharmacy: Building Trust in AI-Based Drug Recommendation

Tags